Serial Number
97338770
Owner
Vita Therapeutics, Inc.Attorney
Rebecca LiebowitzFiling Date
Mar 30, 2022
VITA THERAPEUTICS Trademark
Serial Number: 97338770
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
Legal Representation
Correspondence Address
Rebecca Liebowitz VENABLE LLP
PO BOX 34385
WASHINGTON, DC 20043-9998
United States
Trademark Details
Filing Date
March 30, 2022
Registration Date
Not Registered
Published for Opposition
August 23, 2022
Goods & Services
Cells for medical or clinical use; biological, medicinal and pharmaceutical preparations for the treatment of genetic diseases and disorders; Engineered cells for medical or clinical use, namely, for creating cell and gene therapies for treatment of medical conditions; Living cells for medical use; Drug delivery agents in the form of medically engineered cells for use in targeted drug delivery for a wide variety of pharmaceuticals; medically engineered cells for medical use in targeted drug delivery for a wide variety of pharmaceuticals; cell biological products for medical purposes, namely, induced pluripotent stem cells; Pluripotent stem cells for medical or veterinary use for cell and gene therapies
Engineered cells for scientific, laboratory or medical research; medically engineered cells for scientific and research use in targeted drug delivery for a wide variety of pharmaceuticals
Research and development in the field of cells for medical or clinical use; research and development in the fields of genetic diseases and disorders; pharmaceutical drug development services; Clinical research in the field of personalized therapies and universal therapies through cellular and genome modification; research and development services in the field of gene editing, genome modification, cell engineering, cellular therapy and gene therapy; medical and scientific laboratory services, namely, development of induced pluripotent stem cells; scientific research on the development and production of pluripotent stem cells
